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Introduction
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Breast cancer is the second leading cause of cancer death among women and results in 33 millions of new cases every year [1] . Often assuming regulatory roles in eukaryotic 34 
Materials and methods
91
Process overview
92
Schematic representation of data processing and analysis is shown (Fig 1) . XGBoost 93 and random forest algorithms were employed for feature selection, and the results were 94 used for the subsequent processing step. Subsequently, MIC value for any two nodes 95 was calculated, so that the weight network of expression data can be obtained. iterations of weak classifiers. Similar to random forests, each classifier is also a 137 decision tree. Consider this similarity between random forest and XGBoost, to avoid 138 missing important cancer-associated molecules, the results of feature selection of 139 these two algorithms were merged into one set as the final feature set. The 140 construction of the decision tree in the random forest algorithm is independent, 141 however, in the XGBoost algorithm, classifiers are not independent to each other, 142 every latter classifer is optimized based on the classifer result of the previous one. 143
Formally, the mathematical model of XGBoost can be presented as the following 144 formula: 145 
The adjacency matrix in cross-layer E  is denoted as: 178
In this study, a single layer network was established between miRNAs, and another 180 single layer network was composed of proteins, which together constituted a two-tier 181 multilayer network. The structure of a multi-layered network can sort out the internal 182 interactions of the same kind of molecules while also taking into account the 183 interactions of different kinds of molecules. Thanks to multilayer structure, in the 184 process of cancer-associated biomarker recognition, the identification of a molecule 185 will no longer be limited to the interaction of the same kind of molecules. 
Finally, the importance score of node k in the miRNA network is: 214
In the same way, calculate the score of the protein molecule as The error rate, logic loss, AMSE of the training and testing datasets (Fig 3a) gradually 225 decrease in the model, and the AUC (Fig 3a) 
240
Error rate logic loss and RMSE of the training and testing datasets decrease in the 241 model, whereas the AUC gradually increases then stabilizes after 30 iterations (Fig 3a) . accuracy of tumor and normal tissue in breast cancer (Fig 3b) . 
Random forest for feature selection
262
To estimate the accuracy of the classification, 10-fold cross-validation method was 263 used to assess the classification model (Table 1) . When the number of selected miRNAs 264 is 50 in the breast cancer dataset, the cross-validation accuracy rate is 98.50%. 265 was plotted (Fig 4) . The cancer network (Fig 4a) is sparser than the normal network 301 (Fig 4b) . This finding indicates that the interaction of miRNA networks differs 302 While the number of nodes varies inappreciably when MIC threshold is set to 0.35, the 325 17 number of connections between nodes is significantly reduced, suggesting that these 326 complex networks are distinct. 327 328 Several principles were considered when selecting a threshold. Firstly, the MIC 329 threshold selected must not lead to the loss of too many nodes. For instance, in the 330 analytical process described, less than 5% of nodes are lost. Secondly, the number of 331 edges of the network could not be too small, and the number of edges of the two 332 networks must be significantly different. Number of edges in the miRNA network of 333 normal tissue (Fig 6b) is about 1.59 times that in the miRNA network of cancer tissue 334 (Fig 6a) . 335 (Fig 7) , it was be found that when the MIC threshold is 0.35, the decrease in the number 344 of network nodes is not obvious, effectively fulfilling the first principle of threshold 345 selection. Difference in the number of edges between the two networks is also kept at a 346 relatively high level; that is, this MIC threshold could effectively differentiate the two 347 
Multilayer network
359
Multilayer networks were generated after calculating MIC between nodes and setting 360 MIC thresholds to 0.2, 0.35, or 0.5 (Fig 8) . previously published studies were confirmed (Table 3) . 390 miR-155 expression is upregulated in breast cancer cells, which reduces the levels of RAD51 and affects the cellular response to ionizing radiation.
mir-193a [36]
miR-193a expression is downregulated in breast cancer cell lines and tissues when compared with the adjacent non-tumor tissues.
mir-365b [37]
miR-365 expression levels are significantly higher in breast cancer tissues when compared with adjacent non-tumor tissues.
mir-1301 [38]
miR-1301 is overexpressed in breast cancer tissues and cell lines and cell tissues, whereas downregulation of miR-1301 inhibits the proliferation of breast cancer cells in vitro.
mir-200c [39]
For the claudin-low breast cancer, miR-200c has therapeutic effects in an in vivo model.
mir-10a [40]
The median expression levels of miR-10b in tumor tissue when compared with adjacent non-tumor tissue are significantly higher in relapsed patients than in relapse-free patients.
mir-148b [41]
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature.
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Among the selected proteins, we were able to confirm the relationships of the top 10 393 proteins with breast cancer using published literature (Table 4) . 394 
E-cadherin is regulated epigenetically via methylation of the promoter in most intraductal breast carcinomas.
Caveolin-1-R-V [25]
Caveolin-1 expression is significantly decreased in breast cancer-associated fibroblasts compared to normal fibroblasts and is associated with increased invasion-promoting capacity.
PI3K-p85-R-V [27]
The inhibition of PI3K promotes ER activity, as manifested by increases in ER binding to target promoters and ER target gene expression.
Collagen_VI-R-V [28]
Collagen VI are upregulated in breast cancer, generating a microenvironment that promotes tumour progression and metastasis.
Rictor-R-C [42]
Rictor expression is upregulated significantly as compared with nonmalignant tissues in invasive breast cancer specimens.
Rab11-R-E [43]
Rab coupling protein (FIP1C), an effector of the Rab11 GTPases, is amplified and overexpressed in 10% to 25% of primary breast cancers.
c-Myc-R-C [44]
In the AhR/HDAC6/c-Myc signaling pathway, phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer.
CDK1-R-V [45]
Combined inhibition of Cdk1 and PARP in BRCA-wild-type cancer cells (breast cancer-associated cell) results in reduced colony 22 formation, delayed growth of human tumor xenografts.
14-3-3_zeta-R-V [46]
ErbB2 and 14-3-3ζ overexpression promotes cell migration and antagonizes cell adhesion.
mTOR-R-V [47]
The PI3K/Akt/mTOR pathway results in cell growth and tumor proliferation, and it plays a significant role in endocrine resistance in breast cancer.
Discussion
396
The multilayer network analysis proposed helps identify miRNAs and proteins that 397 could be associated with breast cancer. While biomarkers were previously selected 398 using machine learning, this study is novel in that a combination of machine learning 399 and multilayer network methods was used. 
